REPORTS

Let’s Pullulate and Expand Your Business

Drug Discovery Technologies Market - Global Professional Analysis and Forecast to 2026

Nov 16, 2019  |  164 PAGES  |  REPORT CODE: CMM239570
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Drug Discovery Technologies market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.4% during the forecast period.

This report presents the market size and development trends by detailing the Drug Discovery Technologies market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Drug Discovery Technologies market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Drug Discovery Technologies industry and will help you to build a panoramic view of the industrial development.

Drug Discovery Technologies Market, By Type:

  • Biochips

  • High throughput screening

  • Pharmacogenomics

  • Genomics

  • Bioanalytical instruments

  • Bioinformatics

  • Nanotechnology

  • Others (RNAi, combinatorial chemistry)

Drug Discovery Technologies Market, By Application:

  • Biopharmaceutical companies

  • Pharmaceutical companies

  • Research institutes

  • Biotech companies

Some of the leading players are as follows:

  • Arqule Inc.

  • Bayer Healthcare AG

  • Agilent Technologies, Inc

  • Affymetrix Inc.

  • GE Healthcare Ltd.

  • Novartis AG

  • Abbott Laboratories, Inc.

  • Luminex Corporation

  • Albany Molecular Research Inc.

  • Astrazeneca plc

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Drug Discovery Technologies Market: Technology Type Analysis

  • 4.1 Drug Discovery Technologies Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Drug Discovery Technologies Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Biochips

    • 4.3.2 High throughput screening

    • 4.3.3 Pharmacogenomics

    • 4.3.4 Genomics

    • 4.3.5 Bioanalytical instruments

    • 4.3.6 Bioinformatics

    • 4.3.7 Nanotechnology

    • 4.3.8 Others (RNAi, combinatorial chemistry)

5 Drug Discovery Technologies Market: Product Analysis

  • 5.1 Drug Discovery Technologies Product Market Share Analysis, 2018 & 2026

  • 5.2 Drug Discovery Technologies Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Drug Discovery Technologies Market: Application Analysis

  • 6.1 Drug Discovery Technologies Application Market Share Analysis, 2018 & 2026

  • 6.2 Drug Discovery Technologies Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Biopharmaceutical companies

    • 6.3.2 Pharmaceutical companies

    • 6.3.3 Research institutes

    • 6.3.4 Biotech companies

7 Drug Discovery Technologies Market: Regional Analysis

  • 7.1 Drug Discovery Technologies Regional Market Share Analysis, 2018 & 2026

  • 7.2 Drug Discovery Technologies Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Arqule Inc.

    • 9.1.1 Arqule Inc. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Bayer Healthcare AG

    • 9.2.1 Bayer Healthcare AG Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Agilent Technologies, Inc

    • 9.3.1 Agilent Technologies, Inc Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Affymetrix Inc.

    • 9.4.1 Affymetrix Inc. Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 GE Healthcare Ltd.

    • 9.5.1 GE Healthcare Ltd. Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Novartis AG

    • 9.6.1 Novartis AG Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Abbott Laboratories, Inc.

    • 9.7.1 Abbott Laboratories, Inc. Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Luminex Corporation

    • 9.8.1 Luminex Corporation Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Albany Molecular Research Inc.

    • 9.9.1 Albany Molecular Research Inc. Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Astrazeneca plc

    • 9.10.1 Astrazeneca plc Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 100 Figures and 137 Tables)

  • Figure Biochips Drug Discovery Technologies market, 2015 - 2026 (USD Million)

  • Figure High throughput screening Drug Discovery Technologies market, 2015 - 2026 (USD Million)

  • Figure Pharmacogenomics Drug Discovery Technologies market, 2015 - 2026 (USD Million)

  • Figure Genomics Drug Discovery Technologies market, 2015 - 2026 (USD Million)

  • Figure Bioanalytical instruments Drug Discovery Technologies market, 2015 - 2026 (USD Million)

  • Figure Bioinformatics Drug Discovery Technologies market, 2015 - 2026 (USD Million)

  • Figure Nanotechnology Drug Discovery Technologies market, 2015 - 2026 (USD Million)

  • Figure Others (RNAi, combinatorial chemistry) Drug Discovery Technologies market, 2015 - 2026 (USD Million)

  • Figure Biopharmaceutical companies market, 2015 - 2026 (USD Million)

  • Figure Pharmaceutical companies market, 2015 - 2026 (USD Million)

  • Figure Research institutes market, 2015 - 2026 (USD Million)

  • Figure Biotech companies market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Drug Discovery Technologies market, by country, 2015 - 2026 (USD Million)

  • Table North America Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table North America Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table North America Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Canada Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Canada Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Europe Drug Discovery Technologies market, by country, 2015 - 2026 (USD Million)

  • Table Europe Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Europe Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Europe Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Germany Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Germany Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table France Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table France Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Italy Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Italy Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Spain Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Spain Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug Discovery Technologies market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table China Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table China Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Japan Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Japan Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table India Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table India Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Drug Discovery Technologies market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table MEA Drug Discovery Technologies market, by country, 2015 - 2026 (USD Million)

  • Table MEA Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table MEA Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table MEA Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Drug Discovery Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Drug Discovery Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Drug Discovery Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Arqule Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Healthcare AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Agilent Technologies, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Affymetrix Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GE Healthcare Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Laboratories, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Luminex Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Albany Molecular Research Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Astrazeneca plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top